Thomas Wubben, MD, PhD
Dr. Wubben graduated Summa Cum Laude with a degree in chemical engineering from University of Illinois at Urbana-Champaign. He then proceeded to obtain his M.D. with Honors from the University of Illinois at Chicago while obtaining numerous accolades and publications for his PhD studies. Dr. Wubben completed his ophthalmology residency and vitreoretinal surgical fellowship at the University of Michigan, Kellogg Eye Center. Now, as an Assistant Professor in the Department of Ophthalmology and Visual Sciences at the University of Michigan, his goal is to identify a viable human therapy that reduces morbidity and improves vision in those affected by retinal disorders. As a vitreoretinal surgeon, he has extensive training in vitreoretinal disorders, including macular degeneration, diabetic retinopathy, retinal dystrophies, and retinal detachment. As a basic research scientist, he has extensive experience in drug discovery, design, and development and the molecular genetics and biochemistry that govern cell survival in the retina. Building upon these foundations, his research program currently uses advanced techniques in mass spectrometry-based metabolomics to improve our understanding of the metabolic signals that drive retinal cell function and survival and ultimately, to identify novel therapeutic paradigms to improve vision in those affected by retinal disorders, including macular degeneration.